Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May;107(5):1057-1058.
doi: 10.1002/cpt.1711. Epub 2019 Nov 30.

Overcoming Regulatory Aversion to Novel Methods of Evidence Generation

Elodie Baumfeld Andre  1 , Peter K Honig  2
Affiliations
Comment

Overcoming Regulatory Aversion to Novel Methods of Evidence Generation

Elodie Baumfeld Andre et al. Clin Pharmacol Ther. 2020 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Drs. Baumfeld Andre and Honig are employees of Pfizer and any opinions expressed here are their own and do not represent the views of Pfizer, Inc. As an Associate Editor for Clinical Pharmacology & Therapeutics, Peter K Honig was not involved in the review or decision process for this paper.

Comment on

References

    1. Hutt, P.B. The evolution of federal regulation of human drugs in the United States: an historical essay. Am. J. Law 44, 403–445 (2018). - PubMed
    1. Honig, P. & Zhang, L. Regulation and innovation: role of regulatory science in facilitating pharmaceutical innovation. Clin. Pharmacol. Ther. 105, 778–781 (2019). - PubMed
    1. Prescription Drug User Fee Act ( PDUFA ) .VI: fiscal year 2018–2022 <https://www.fda.gov/media/99140/download>. Accessed September 23, 2019.
    1. Eichler, H.‐G. et al Are novel, non‐randomised analytic methods fit for decision‐making? The need for prospective, controlled and transparent validation. Clin. Pharmacol. Ther. 107, 773–779 (2020). - PMC - PubMed
    1. Blincyto ™ ( blinatumomab ) . Approval Letter and FDA Review Documents <https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/125557Orig1s005T...>. Accessed September 23, 2019.